Lenalidomide Capsule
Product Images NDC 63304-044
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Lenalidomide (NDC 63304-044). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image 2 (Image 03)
Label 1 (Label 1)
Label 2 (Label 2)
Label 3 (Label 3)
Label 4 (Label 4)
Spl-lenalidomdie-structure (Spl Lenalidomdie Structure)
Spl-lenalidomide-image 08 (Spl Lenalidomide Image 08)
Spl-lenalidomide-image 09 (Spl Lenalidomide Image 09)
Spl-lenalidomide-image 4 (Spl Lenalidomide Image 4)
Spl-lenalidomide-image 5 (Spl Lenalidomide Image 5)
This appears to be a graph or chart showing the proportion of subjects in a study and a Kaplan-Meier estimate of time to progression, specifically for Stage 1. It also indicates a Hazard Ratio and Log Rank test result. The x-axis shows time to progression in months and the y-axis displays the proportion of subjects.*
Spl-lenalidomide-image-01 (Spl Lenalidomide Image 01)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.